The U.S. Food and Drug Administration declined to approve a drug developed by Sanofi SA and Lexicon Pharmaceuticals Inc intended for use with insulin in patients with type 1 diabetes, the companies said on Friday.
from Reuters: Health https://ift.tt/2FtWiL6
via
IFTTT
0 comments: